Home Regulation of the Hepatic Endothelin System in Advanced Biliary Fibrosis in Rats
Article
Licensed
Unlicensed Requires Authentication

Regulation of the Hepatic Endothelin System in Advanced Biliary Fibrosis in Rats

  • Lars Rothermund , Stefan Leggewie , Anja Schwarz , Christa Thöne-Reinecke , Jae Jin Cho , Christian Bauer , Martin Paul , Hans-H. Neumayer , Detlef Schuppan and Berthold Hocher
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 38 Issue 6

Abstract

The aim of the present study was to analyze the hepatic endothelin system and its regulation in liver cirrhosis due to bile duct obstruction. Wistar rats were subjected for 6 weeks to: 1) sham operation; 2) bile duct obstruction; 3) bile duct obstruction and the selective oral endothelin A receptor antagonist LU 135252; 4) bile duct obstruction and oral silymarin, a hepatoprotective and antifibrotic compound. We determined tissue concentrations of endothelin-1 and big-endothelin-1 by ELISA and the density of both endothelin receptor subtypes in plasma membrane fractions by Scatchard analysis.

The hepatic endothelin system in liver cirrhosis due to chronic bile duct obstruction is characterized by a simultaneous up-regulation of both endothelin-1 tissue concentration (7.2 fold compared to sham operation; p<0.001) as well as the density of both endothelin receptor subtypes (ETA 7.4-fold, ETB 4.9-fold, p<0.001, respectively) suggesting a synergistic activation of the hepatic endothelin system in this rat model of non-inflammatory cirrhosis. Treatment with proven antifibrotic agents such as silymarin or a selective endothelin-A-receptor blocker (LU 135252) did not reduce the activity of the hepatic endothelin system, suggesting that the hepatic endothelin system is not activated by the fibrotic process itself.

:
Published Online: 2005-06-01
Published in Print: 2000-06-11

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Integrons: an Antibiotic Resistance Gene Capture and Expression System
  2. Levels of C-Telopeptide Fragments of Collagen Type I Enable the Monitoring and Early Adjustment of Clodronate Therapy in Patients with Postmenopausal Osteoporosis
  3. Probable Involvement of Cathepsin D in the Degradation of β2-Microglobulin in Acidic Urine
  4. Autoantibodies against Oxidized Low-Density Lipoprotein Correlate with Achilles Tendon Xanthomas
  5. Regulation of the Hepatic Endothelin System in Advanced Biliary Fibrosis in Rats
  6. Determination of Plasma Methoxyamines
  7. Stability of Brain Natriuretic Peptide (BNP) in Human Whole Blood and Plasma
  8. Effect of Short- and Long-Term Storage on Human Serum and Recombinant Apolipoprotein E Concentration
  9. Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio
  10. The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population
  11. A Model for Setting Analytical Quality Specifications and Design of Control for Measurements on the Ordinal Scale
  12. Transformation in the PC-Aided Biochemical Data Analysis
  13. Concordance of Eight Kits for Antithyroid Peroxidase Autoantibodies Determination
  14. Evaluation of a Point-of-Care System for Quantitative Determination of Troponin T and Myoglobin
  15. The Maillard Reaction in Foods and Medicine. By John OBrien, Harry E. Nursden, M. James, C. Crabbe and Jennifer M. Ames, editors
  16. Apoptosis and Inflammation. By J.D. Winkler, editor
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.074/html
Scroll to top button